Dr. Cherry is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Renown Regional Medical Center
1155 Mill St
Reno, NV 89502
Summary
- ABIM-certified Hospitalist Physician and Medical Director of inpatient cancer unit. Specialties include acute care of oncology patients, goals-of-care conversations, advance care planning, and end-of-life care. Physician-Scientist with graduate education in cancer biology and clinical research in AML.
Education & Training
- University of ColoradoResidency, Internal Medicine, 2017 - 2020
- Texas A&M; Health Science Center College of MedicineClass of 2017, MD PHD
Certifications & Licensure
- NV State Medical License 2020 - 2025
- TX State Medical License 2006 - 2008
- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 98 citationsVenetoclax and Azacitidine Compared to Induction Chemotherapy for Newly Diagnosed Patients with Acute Myeloid Leukemia.Evan Cherry, Diana Abbott, Maria L. Amaya, Christine McMahon, Marc Schwartz
Blood Advances. 2021-10-05 - 8 citationsThe propriety of upgrading responses to venetoclax + azacitidine in newly diagnosed patients with acute myeloid leukemiaDiana Abbott, Evan Cherry, Maria L. Amaya, Christine McMahon, Marc Schwartz
Leukemia & Lymphoma. 2021-05-12 - 40 citationsAdult cord blood transplant results in comparable overall survival and improved GRFS vs matched related transplant.Prashant Sharma, Enkhtsetseg Purev, Bradley M. Haverkos, Daniel A. Pollyea, Evan Cherry
Blood Advances. 2020-05-26
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: